Positive Late-breaking Clinical Trial Data for the EkoSonic™ Endovascular System Presented at VIVA21
PE remains a life-threatening and complex disease, but these results provide an opportunity to advance patient care by showcasing evidence that proves a lower drug dose and shorter infusion duration of a thrombolytic agent may result in enhanced safety and efficacy," said Keith M. Sterling, M.D., FSIR, Inova Alexandria Hospital, Alexandria, VA, study principal investigator.
SyncThink Receives Second FDA Clearance for EYE-SYNC Platform; the First Mobile, Rapid Test for Concussion
EYE-SYNC previously received the prestigious Breakthrough Device Designation from the FDA in 2019, following the initial clearance and commercialization of the technology platform in 2017.
American Academy of Nursing Announces 2021 Election Results
“The Academy is pleased to announce the Fellows, elected by their peers, who will be assuming leadership positions within the organization following the conclusion of this year’s hybrid Health Policy Conference,” said Academy President Eileen Sullivan-Marx, PhD, RN, FAAN.
An Interview with Dr. Robert Steensen Orthopedic Surgeon on Kinematic Alignment
Kinematic alignment is a technique to place a knee implant where the native knee was prior to the development of arthritis. Read what Dr. Steensen has to say about the positives including seeing patients getting back to full function, faster!
Boston Scientific Announces Positive Late-Breaking Clinical Trial Data for the Ranger™ Drug-Coated Balloon
The data included two-year results from the RANGER II SFA randomized controlled trial, confirming the safety and efficacy of the Ranger DCB compared to standard percutaneous transluminal angioplasty (PTA) for the treatment of patients with peripheral artery disease (PAD) in the superficial femoral artery (SFA) and proximal popliteal artery (PPA).